Tower Research Capital (TRC)’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01K | Sell |
1,351
-2,078
| -61% | -$6.17K | ﹤0.01% | 4396 |
|
|
2025
Q1 | $7.82K | Buy |
3,429
+1,932
| +129% | +$4.41K | ﹤0.01% | 3931 |
|
|
2024
Q4 | $5.6K | Sell |
1,497
-1,235
| -45% | -$4.62K | ﹤0.01% | 4267 |
|
|
2024
Q3 | $8.2K | Buy |
+2,732
| New | +$8.2K | ﹤0.01% | 3976 |
|
|
2022
Q2 | – | Sell |
-102
| Closed | -$1K | – | 6607 |
|
|
2022
Q1 | $1K | Buy |
102
+45
| +79% | +$441 | ﹤0.01% | 5871 |
|
|
2021
Q4 | $0 | Buy |
57
+25
| +78% | – | ﹤0.01% | 6652 |
|
|
2021
Q3 | $0 | Buy |
+32
| New | – | ﹤0.01% | 6256 |
|
|
2017
Q2 | – | Sell |
-5
| Closed | – | – | 3661 |
|
|
2017
Q1 | $0 | Sell |
5
-1
| -17% | – | ﹤0.01% | 4054 |
|
|
2016
Q4 | $1K | Sell |
6
-7
| -54% | -$1.17K | ﹤0.01% | 3674 |
|
|
2016
Q3 | $1K | Buy |
13
+5
| +63% | +$385 | ﹤0.01% | 3392 |
|
|
2016
Q2 | $1K | Sell |
8
-5
| -38% | -$625 | ﹤0.01% | 4235 |
|
|
2016
Q1 | $1K | Buy |
13
+9
| +225% | +$692 | ﹤0.01% | 3817 |
|
|
2015
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 4190 |
|
|
2013
Q3 | – | Sell |
-3
| Closed | -$4K | – | 4899 |
|
|
2013
Q2 | $4K | Buy |
+3
| New | +$4K | ﹤0.01% | 3134 |
|